Principal Display Panel (150 mg Tablet Container)
Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 16729-444
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 16729-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (300 mg Tablet Container)
This is a medication called ZYBAN® that contains 300mg bupropion hydrochloride USP in an extended-release tablet. It is usually taken once daily, according to prescribed instructions. The medication should be stored between 15°C and 30°C, protected from light, and preserved in a well-closed container. It is manufactured by Accord Healthcare, Inc. and comes with a medication guide to be given to each patient. The text also includes the NDC code and information about the manufacturer.*
Wellbutrin Chemical Structure (Bupropion Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
